查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2143342

信使核糖核酸 (mRNA) 加帽酶市場：按產品類型、應用、最終用戶、國家和地區分類—全球產業分析、市場規模、市場佔有率和預測（2026-2033 年）

Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, By Product Type, By Application, By End User, By Country, and By Region -Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
出版日期: | 出版商: AnalystView Market Insights | 英文 350 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年，信使核糖核酸 (mRNA) 加帽酶市值將達到 10.634 億美元，並將在 2026 年至 2033 年期間以 15.1% 的複合年成長率成長。

mRNA加帽酶是一類蛋白質複合物，它們將7-甲基鳥苷帽連接到新合成的mRNA轉錄本的5'端，以確保RNA分子的穩定性，並將RNA從細胞核轉運至細胞外，促進RNA翻譯。這些加帽酶的結構包含三個蛋白質酶活性位點，它們可以獨立發揮作用，也可以作為RNA聚合酵素II複合物的一部分發揮作用。這些活性位點包括一個作為RNA三磷酸酶的加帽酶，負責去除新合成的mRNA轉錄物的末端磷酸基團；一個作為鳥苷酸轉移酶的加帽酶，負責將GTP衍生的GMP連接到mRNA的5'二磷酸基團上；以及一個作為N7甲基轉移酵素酶的加帽酶。因此，mRNA加帽酶在確保mRNA的正確成熟和功能性基因表現方面發揮著至關重要的作用。

信使核糖核酸（mRNA）加帽酶市場 - 市場動態

擴大個人化醫療的應用將促進市場成長。

體外受精（IVF）中個人化醫療的日益普及推動了信使核糖核酸（mRNA）加帽酶市場的成長。這是因為該酵素能夠利用胚胎的遺傳組成對其進行特定分析，從而輔助胚胎選擇，促進生育決策流程，並有助於識別與遺傳異常相關的風險。例如，根據巴西臨床試驗註冊中心的數據，截至2026年2月，個人化醫療在難治性骨髓惡性腫瘤中的應用正在不斷擴展，CAR-T細胞（靶向腫瘤抗原的基因修飾T淋巴細胞）療法取得了顯著療效。巴西正致力於在研究、臨床實踐和監管領域建立獨特的能力和專業知識，以便未來為患者提供此類先進的個人化療法。

根據巴西臨床試驗註冊中心的數據，目前共有18,826項臨床試驗，其中9,632項正在招募受試者，5,192項正在招募參與者，89項正在進行資料分析，6,240項處於草案階段。這一趨勢可望加速個人化胚胎選擇，並提高體外受精（IVF）治療策略的精準度。

信使核糖核酸（mRNA）加帽酶市場－市場區隔分析：

全球信使核糖核酸 (mRNA) 加帽酶市場按產品類型、應用、最終用戶和地區進行細分。

在信使核糖核酸 (mRNA) 加帽酶市場中，重組信使核糖核酸 (mRNA) 加帽酶佔據了相當大的佔有率，尤其是在用於 5' mRNA 加帽的人工 mRNA 的研究和商業化領域，重組酶（例如痘苗病毒加帽酶 (VCE)）被廣泛應用。 2026 年 3 月，羅氏宣布推出含有重組 mRNA 鳥苷醯轉移酶和 2'O-甲基轉移酵素酶的痘苗病毒加帽系統。此痘苗病毒加帽系統符合 GMP 品質標準，且不含動物性成分。此舉可望擴大重組酶在 mRNA 生產中的應用。

信使核糖核酸 (mRNA) 加帽酶市場－區域分析

由於高度依賴進口試劑，北美是受影響最嚴重的地區之一。供應鏈和採購方面可能會出現許多挑戰。例如，根據美國海關和邊防安全的規定，自2025年11月起，所有進口到美國的生物材料，包括遺傳物質、酵素、蛋白質、胜肽、診斷檢體、培養細胞、抗體和其他研究材料，都必須符合進口文件、標籤、包裝、申報和檢測方面的要求。如果生物材料的商業性價值超過2,500美元，則需要辦理正式的海關手續（包括繳納保證金、關稅、稅金和費用）。

如果貨物價值低於 800 美元且需要合作政府機構 (PGA) 的參與，進口商可以使用「86 號申報類型」進行電子申報。此外，美國海關與邊防安全局 (CBP) 將生物材料定義為七類：培養細胞和組織、診斷檢體、遺傳物質、基因改造生物、人類和獸用產品、傳染性物質以及微生物。這些法規的複雜性可能會對供應鏈造成額外負擔，並導致難以及時獲得所需的特殊試劑。

由於研究活動的活性化和生物技術的進步，亞太地區信使核糖核酸（mRNA）加帽酶市場預計將持續成長。例如，根據墨卡託中國研究中心的數據，截至2025年4月，中國國家藥品監督管理局（NMPA）已核准76種新藥上市，較上年同期成長53%，其中85%由中國企業研發。 2025年上半年，感染疾病疫苗接種量達8,500萬劑。全球進行的多區域臨床試驗中，有三分之一在亞太地區進行。大型製藥企業在中國投資了31.5億美元用於分子化合物的研發。全部區域生物技術投資的增加和mRNA研究能力的提升也進一步推動了這一成長。

目錄

第1章：信使核糖核酸 (mRNA) 加帽酶市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章：信使核糖核酸（mRNA）加帽酶市場趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章：信使核糖核酸（mRNA）加帽酶的產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景展望圖
  • 管理體制分析

第5章：信使核糖核酸（mRNA）加帽酶市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：信使核糖核酸（mRNA）加帽酶的市場狀況

  • 信使核糖核酸 (mRNA) 加帽酶市場佔有率分析，2025 年
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章 信使核糖核酸 (mRNA) 加帽酶市場：依產品類型分類

  • 概述
    • 基於細分市場的市場佔有率分析：按產品類型
    • 天然來源的mRNA加帽酶
      • 蓋2 封端酶
      • 0號封蓋酶
      • 帽1封端酶
    • 重組mRNA加帽酶
      • 鳥嘌呤-N7-甲基轉移酵素
      • 鳥苷醯轉移酶
      • RNA三磷酸酶
      • 痘苗病毒加帽酶（VCE）

第8章 信使核糖核酸 (mRNA) 加帽酶市場：依應用領域分類

  • 概述
    • 基於細分市場的市場佔有率分析：按應用領域
    • 診斷
    • 研究與開發
    • 治療
    • 其他

第9章 信使核糖核酸 (mRNA) 加帽酶市場：依最終用戶分類

  • 概述
    • 基於細分市場的市場佔有率分析：按最終用戶分類
    • 研究機構
    • 契約製造公司（CMO）
    • 製藥和生物技術公司
    • 其他

第10章 信使核糖核酸 (mRNA) 加帽酶市場：依地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商：歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 丹麥
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商：亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 台灣
    • 越南
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商：中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 伊朗
    • 卡達
    • 其他中東和非洲國家

第11章 主要供應商分析：信使核糖核酸 (mRNA) 加帽酶產業

  • 競爭基準
    • 競爭對手儀錶板
    • 競爭定位
  • 公司簡介
    • Roche AG
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Takara Bio Inc.
    • Aldevron
    • New England Biolabs Inc.
    • CellScript Inc.
    • Yeasen Biotechnology Co. Ltd.
    • Novoprotein Scientific Inc.
    • TriLink Biotechnologies LLC
    • Jena Bioscience GmbH
    • Vazyme Biotech Co. Ltd.
    • Enzynomics Inc.
    • Creative Enzymes
    • Canvax Biotech SL
    • APExBIO Technology LLC
    • BOC Sciences
    • KACTUS Biosystems
    • Others

第12章：AnalystView 的全景視圖

簡介目錄
Product Code: ANV7536

Messenger Ribonucleic Acid (mRNA) Capping Enzyme market size was valued at US$ 1,063.4 Million in 2025, expanding at a CAGR of 15.1% from 2026 to 2033.

The mRNA capping enzyme is a protein complex that is involved in the addition of a 7-methylguanosine cap to the 5' end of the newly formed mRNA transcript for the stability of the RNA molecule, RNA export from the nucleus, and the RNA translation process. The structure of the enzyme that acts as a capping enzyme contains three active centers of protein enzymes, which can function either independently or as a part of the RNA polymerase II complex. These active centers include the capping enzyme, which acts as RNA triphosphatase and removes terminal phosphates from the newly synthesized mRNA transcripts; the capping enzyme, which acts as guanylyl transferase and attaches the GMP from GTP to the 5' diphosphate of the mRNA; and the capping enzyme, which acts as N7 methyl transferase. Thus, mRNA capping enzymes play a pivotal role in ensuring proper mRNA maturation and functional gene expression.

Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market- Market Dynamics

Increasing Use Of Personalized Medicine To Boost Market Expansion

Increasing adoption of personalized medicine in IVF is driving Messenger Ribonucleic Acid (mRNA) Capping Enzyme market because it helps in profiling the embryos in a particular way using the genetic constitution of the embryos, helps in the selection of embryos, makes the decision-making process with regard to reproduction easier, and also helps in risk identification related to genetic abnormalities. For instance, in February 2026, according to the Brazilian Registry of Clinical Trials (Gov), there is growing use of personalized medicine because these are providing excellent results and outcomes in refractory hematologic malignancies where CAR-T cells are genetically modified T-lymphocytes against the tumor antigen. The country is working towards building its own capacity and expertise in research, clinics, and regulations so that it can provide patients with such advanced personalized treatments in the future.

As per the Brazil Registry of Clinical Trials, there are a total of 18,826 clinical trials, including 9,632 active registrations of clinical trials, 5,192 recruiting clinical trials, 89 ongoing analysis trials, and 6,240 drafted clinical trials. This trend is expected to accelerate personalized embryo selection and strengthen precision in IVF treatment strategies.

Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market- Segmentation Analysis:

The Global Messenger Ribonucleic Acid (mRNA) Capping Enzyme market is segmented on the basis of Product Type, Application, End User, and Region.

In the Messenger Ribonucleic Acid (mRNA) Capping Enzyme market, recombinant Messenger Ribonucleic Acid (mRNA) capping enzymes hold a prominent share due to the extensive use of recombinant enzymes like Vaccinia Capping Enzyme (VCE) in artificial mRNA studies and commercialization, especially for 5' mRNA capping purposes. In March 2026, Roche AG introduced its Vaccinia Capping System, which includes recombinant mRNA guanylyltransferase and 2'O-methyltransferase enzymes. The Vaccinia Capping System provides capping, which is of GMP quality and has no animal origin. This move is anticipated to increase the use of recombinant enzymes in mRNA production.

Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market- Geographical Insights

North America is among the most affected regions because of being heavily reliant on imported reagents. It may pose some challenges in terms of supply chains and the difficulties in procurement. For instance, in November 2025, according to U.S. Customs and Border Protection (Gov.), all biological materials imported into the USA, including genetic materials, enzymes, proteins, peptides, diagnostic specimens, cultured cells, antibodies, and other research materials, have to meet the requirements of import documentation, labeling, packaging, declaration, and inspection. If the commercial value of biological materials is higher than $2,500, it will require the formal customs entry process (bonding and duties/taxes/fees).

In case the value is lower than $800, an importer can use the Entry Type 86 electronic filing method if Partner Government Agency (PGA) participation is needed. Also, there are seven categories of biological materials provided by the CBP, which include cultured cells/tissues, diagnostic specimens, genetic materials, genetically modified organisms, human/veterinary products, infectious substances, and microorganisms. This regulatory complexity can further strain supply chains and complicate timely access to specialized reagents.

Asia-Pacific is anticipated to be a growing region in the Messenger Ribonucleic Acid (mRNA) Capping Enzyme market due to increased research activities and biotechnological advancements. For instance, in April 2025, according to the Mercator Institute for China Studies (org), the National Medical Products Administration (NMPA) of China had approved a total of 76 new drugs. This marked a 53% increase in the number of new medicines, with 85% of those having been invented by the companies from China. In the first six months of 2025, the number of vaccinations administered to protect people from novel coronavirus disease was 85 million. One-third of all the multi-regional clinical trials conducted globally were taking place in the Asia-Pacific region. The major pharmaceutical companies spent $3.15 billion in Chinese molecules. This growth is further supported by expanding biotechnology investments and mRNA research capabilities across the region.

Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market- Competitive Landscape:

The competitive landscape of the Messenger Ribonucleic Acid (mRNA) Capping Enzyme market is evolving as key players such as TriLink Biotechnologies, Thermo Fisher Scientific, New England Biolabs, Jena Bioscience, and Aldevron produce next-generation cap analogs used during co-transcription. These analogs guarantee the maximum stability and translation efficiency. In February 2025, TriLink BioTechnologies entered into the non-exclusive license and supply agreement with Aldevron, giving access to the company's mRNA capping technology-CleanCap(R). This collaboration between the two firms looks like it will be highly significant for the future advancement of the mRNA capping technology.

Recent Developments:

In May 2025, TriLink BioTechnologies signed a memorandum of understanding with the International Vaccine Institute for collaborating in the development of mRNA vaccines through knowledge exchange and joint scientific initiatives using mRNA technology.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MESSENGER RIBONUCLEIC ACID (MRNA) CAPPING ENZYME MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Roche AG
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Takara Bio Inc.
  • Aldevron
  • New England Biolabs Inc.
  • CellScript Inc.
  • Yeasen Biotechnology Co. Ltd.
  • Novoprotein Scientific Inc.
  • TriLink Biotechnologies LLC
  • Jena Bioscience GmbH
  • Vazyme Biotech Co. Ltd.
  • Enzynomics Inc.
  • Creative Enzymes
  • Canvax Biotech SL
  • APExBIO Technology LLC
  • BOC Sciences
  • KACTUS Biosystems
  • Others

GLOBAL MESSENGER RIBONUCLEIC ACID (MRNA) CAPPING ENZYME MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020 - 2033

  • Natural Messenger Ribonucleic Acid (mRNA) Capping Enzymes
  • Cap 2 Capping Enzymes
  • Cap 0 Capping Enzymes
  • Cap 1 Capping Enzymes
  • Recombinant Messenger Ribonucleic Acid (mRNA) Capping Enzymes
  • (Guanine-N7)-Methyltransferase
  • Guanylyltransferase
  • RNA Triphosphatase
  • Vaccinia Capping Enzyme (VCE)

GLOBAL MESSENGER RIBONUCLEIC ACID (MRNA) CAPPING ENZYME MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Diagnostics
  • Research And Development
  • Therapeutics
  • Others

GLOBAL MESSENGER RIBONUCLEIC ACID (MRNA) CAPPING ENZYME MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

  • Research Institutions
  • Contract Manufacturing Organizations (CMOs)
  • Pharmaceutical And Biotechnology Companies
  • Others

GLOBAL MESSENGER RIBONUCLEIC ACID (MRNA) CAPPING ENZYME MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. mRNA Capping Enzyme Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
  • 2.2. Competitive Insights

3. mRNA Capping Enzyme Key Market Trends

  • 3.1. mRNA Capping Enzyme Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. mRNA Capping Enzyme Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. mRNA Capping Enzyme Market Opportunities
  • 3.4. mRNA Capping Enzyme Market Future Trends

4. mRNA Capping Enzyme Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. mRNA Capping Enzyme Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. mRNA Capping Enzyme Market Landscape

  • 6.1. mRNA Capping Enzyme Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. mRNA Capping Enzyme Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2025 & 2033 (%)
    • 7.1.2. Natural mRNA Capping Enzymes
      • 7.1.2.1. Cap 2 Capping Enzymes
      • 7.1.2.2. Cap 0 Capping Enzymes
      • 7.1.2.3. Cap 1 Capping Enzymes
    • 7.1.3. Recombinant mRNA Capping Enzymes
      • 7.1.3.1. (Guanine-N7)-Methyltransferase
      • 7.1.3.2. Guanylyltransferase
      • 7.1.3.3. RNA Triphosphatase
      • 7.1.3.4. Vaccinia Capping Enzyme (VCE)

8. mRNA Capping Enzyme Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 8.1.2. Diagnostics
    • 8.1.3. Research And Development
    • 8.1.4. Therapeutics
    • 8.1.5. Others

9. mRNA Capping Enzyme Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
    • 9.1.2. Research Institutions
    • 9.1.3. Contract Manufacturing Organizations (CMOs)
    • 9.1.4. Pharmaceutical And Biotechnology Companies
    • 9.1.5. Others

10. mRNA Capping Enzyme Market - By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. mRNA Capping Enzyme Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. mRNA Capping Enzyme Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.16. Denmark
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.16.3. Denmark Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.16.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.16.5. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.17. Rest of Europe
      • 10.3.17.1. Overview
      • 10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.17.5. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. mRNA Capping Enzyme Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.15. Taiwan
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.15.3. Taiwan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.15.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.15.5. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.16. Vietnam
      • 10.4.16.1. Overview
      • 10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.16.3. Vietnam Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.16.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.16.5. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.17. Rest of APAC
      • 10.4.17.1. Overview
      • 10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.17.5. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. mRNA Capping Enzyme Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. mRNA Capping Enzyme Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.13. Iran
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.13.3. Iran Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.13.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.13.5. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.14. Qatar
      • 10.6.14.1. Overview
      • 10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.14.3. Qatar Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.14.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.14.5. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.15. Rest of MEA
      • 10.6.15.1. Overview
      • 10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.15.5. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

11. Key Vendor Analysis- mRNA Capping Enzyme Industry

  • 11.1. Competitive Benchmarking
    • 11.1.1. Competitive Dashboard
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Roche AG
    • 11.2.2. Thermo Fisher Scientific Inc.
    • 11.2.3. Merck KGaA
    • 11.2.4. Takara Bio Inc.
    • 11.2.5. Aldevron
    • 11.2.6. New England Biolabs Inc.
    • 11.2.7. CellScript Inc.
    • 11.2.8. Yeasen Biotechnology Co. Ltd.
    • 11.2.9. Novoprotein Scientific Inc.
    • 11.2.10. TriLink Biotechnologies LLC
    • 11.2.11. Jena Bioscience GmbH
    • 11.2.12. Vazyme Biotech Co. Ltd.
    • 11.2.13. Enzynomics Inc.
    • 11.2.14. Creative Enzymes
    • 11.2.15. Canvax Biotech SL
    • 11.2.16. APExBIO Technology LLC
    • 11.2.17. BOC Sciences
    • 11.2.18. KACTUS Biosystems
    • 11.2.19. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us